CID 3046918

Morpholine, 4-(2-((1-(4-methylphenyl)-4-phenyl-1h-pyrazol-3-yl)oxy)ethyl)-, monomethanesulfonate

Structural Information

Molecular Formula
C22H25N3O2
SMILES
CC1=CC=C(C=C1)N2C=C(C(=N2)OCCN3CCOCC3)C4=CC=CC=C4
InChI
InChI=1S/C22H25N3O2/c1-18-7-9-20(10-8-18)25-17-21(19-5-3-2-4-6-19)22(23-25)27-16-13-24-11-14-26-15-12-24/h2-10,17H,11-16H2,1H3
InChIKey
RYOVMVCMJQLOCZ-UHFFFAOYSA-N
Compound name
4-[2-[1-(4-methylphenyl)-4-phenylpyrazol-3-yl]oxyethyl]morpholine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

363.19467 Da
Monoisotopic Mass

3.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 364.201946 188.8
[M+Na]+ 386.183888 193.9
[M-H]- 362.187394 197.2
[M+NH4]+ 381.228493 196.5
[M+K]+ 402.157828 189.1
[M+H-H2O]+ 346.191930 176.2
[M+HCOO]- 408.192871 204.7
[M+CH3COO]- 422.208521 197.4
[M+Na-2H]- 384.169336 189.3
[M]+ 363.19412142 187.5
[M]- 363.19521858 187.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.